ALLERTEC

Focusing on the future

Next to the patient, responsibly, reliably, with unique products and high quality services

With devotion, respect and responsibility to human

Allertec Hellas S.A., founded in 1996, is fully connected with the provision of specialized and personalized services to patients at home with serious chronic diseases, providing them with innovative and high quality products. Our main aim is to meet the needs, concerns and upgrade the care for our patients and their home environment. Driven by this commitment, we invest in long-term partnerships with our suppliers, our personnel and all our partners, setting high goals and applying a strict value system with strategic goal the differentiation and a patient-centered approach.

MISSION AND VISION

Our mission is to provide high quality products and services to health professionals and patients for serious and chronic diseases. Our vision is to remain a reliable company towards all our partners.

Quality Policy

Central element of our strategic planning is the monitoring of the regulatory and legal framework that governs the marketing of products. Allertec Hellas supply products and services in accordance with the rules and specifications provided by national and European legislation. The company is certified in accordance with Decision 1348/04 of the Ministry of Health and Welfare and also maintains a quality system based on the principles of ISO 9001:2015.

Pharmacovigilance

ALLERTEC HELLAS S.A. maintains a Pharmacovigilance System which meets the requirements of European and Greek legislation.

The system includes the recording and management of the incoming Adverse Reports, the report to the competent Authorities (EOF / EMA), the submission of the Periodically Updated Safety Reports (PEEA / PSUR), the Control of Scientific / Medical Literature, the Training, the Preparation and Submission of Risk Management Plans and the Continuous Monitoring of the Product Safety Profile.

By the continuous monitoring of the system, we secure the provision of safe products to the patients, which is also a requirement of the company itself.

The Report of Side Effects in relation to our medicinal products is done with the following ways:

  • Electronic submission of the Yellow Card through the website of EOF http://www.eof.gr/web/guest/yellowgenera
  • Printed form by mail, free of charge, to the Department of Undesirable Actions of EOF (284 Mesogeion, 15562) contact phone: 213-2040380 or 213-2040337.

Alternatively the side effects can be reported in the Pharmacovigilance department of ALLERTEC, via the following paths:

  • By e-mail to safety@pharmassist.gr
  • By phone at +30 210 6561435